Cargando…
Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials
Determining the duration of immunity induced by booster doses of CoronaVac is crucial for informing recommendations for booster regimens and adjusting immunization strategies. In two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials, immunogenicity and safety of fou...
Autores principales: | Xin, Qianqian, Wu, Qianhui, Chen, Xinhua, Han, Bihua, Chu, Kai, Song, Yan, Jin, Hui, Chen, Panpan, Lu, Wanying, Yang, Tuantuan, Li, Minjie, Zhao, Yuliang, Pan, Hongxing, Yu, Hongjie, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166693/ https://www.ncbi.nlm.nih.gov/pubmed/35660738 http://dx.doi.org/10.1038/s41467-022-30864-w |
Ejemplares similares
-
Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents
por: Wang, Lei, et al.
Publicado: (2022) -
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
por: Zeng, Gang, et al.
Publicado: (2022) -
Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021) -
Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023) -
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
por: Li, Jingxin, et al.
Publicado: (2022)